Health24.com | Too many sugary sodas might harm your kidneys

Drinking lots of sweetened soda may increase the risk of developing chronic kidney disease, two new studies find.

“Consumption of 500ml of a commercially available soft drink, sweetened with high-fructose corn syrup increased vascular resistance in the kidneys within 30 minutes,” the researchers found.

In a second study, the investigators found changes in blood flow in the kidneys was caused by the corn syrup, not the caffeine, in the soda.

The two studies included a total of 25 healthy men and women, with an average age of 22 to 24.

Millions have chronic kidney disease

Christopher Chapman, of the University at Buffalo in New York, and colleagues explained that vascular resistance occurs when blood vessels constrict, reducing blood flow in the kidneys and increasing blood pressure and impairing kidney function.

“Collectively, our findings indicate that [high-fructose corn syrup]-sweetened soft drink consumption increased renal vasoconstrictor tone at rest and during sympathetic activation,” the study authors said in a news release from the American Physiological Society.

The report was published online recently in the American Journal of Physiology – Renal Physiology.

Nearly 37 million Americans suffer from chronic kidney disease, according to the National Kidney Foundation. The foundation estimates kidney disease kills more people than breast cancer or prostate cancer.

Image credit: Getty 

Share Button

Coronavirus: NHS contact-tracing app in place by end of month, says minister

The app will “be running as soon as we think it is robust”, a government minister says.

Share Button

Health24.com | Running with a mask – what you should know, and how to choose the right one

  • South Africans are now allowed to exercise outdoors between 06:00 and 18:00
  • Masks are still mandatory, but it could make running uncomfortable
  • Luckily, you can choose the most suitable mask for running

_____________________________________________________________________________________________________________________

When South Africa moved to lockdown level 3 on 1 June 2020, the exercise window was extended to 18:00, allowing more time to exercise outdoors.

Runners and walkers now have more time to enjoy the fresh air, but wearing a mask outside is still mandatory. Unfortunately, it can take a while to get used to this. You may notice that your breathing is more laboured than usual (and this is not only because you lost fitness during lockdown level 5) and that you struggle to reach your usual pace.

Your face might also feel hot and the mask or buff might become damp during your run, leading to discomfort and even skin issues.

Why should we run with masks?

While the risk of SARS-CoV-2 infection remains greater indoors, especially in an area without proper ventilation, keeping your distance from others and covering your mouth and nose while out running are still encouraged.

This all has to do with the so-called “breathing stream” that can carry the virus particles, especially when runners breathe heavily and expel more respiratory droplets, which is known to spread the virus.

Some experts have different opinions. Dr Richard Martinello, associate professor of infectious disease at Yale School of Medicine in Connecticut said that it depends where you run and if you are physically distanced or not. If you are running in areas where there is no-one else, a mask may do little to protect you. But if you run in a neighbourhood or area where other people are also out exercising, a mask may reduce any risk.

A mask and your performance

Many runners have been concerned whether running with a mask may cause issues such as hypoxia or increase the amount of carbon dioxide you inhale.

But experts reassure us that a simple cloth mask or buff cannot replicate this effect. Professional athletes train with specialised masks to reduce the amount of oxygen they inhale – this is called “altitude training” and athletes benefit from this because their bodies start producing more red blood cells, which benefits muscles and enhances their performance when they are racing at lower altitudes.

Professor Melissa Perry from the George Washington University explains that a mask remains an important step in reducing virus transmission and is as much an action to protect others as protecting yourself.

She also explains that it is highly unlikely that a cloth mask or buff will replicate the same effects as the specialised masks athletes use for altitude training, and that there is little risk of hypoxia.

But while a normal mask doesn’t reduce oxygen like an altitude mask, Timothy Lyman, a certified personal trainer from Pittsburgh explains that a cloth mask doesn’t change the oxygen saturation, but your lungs and heart still work harder, increasing the effort of your diaphragm, and thereby your endurance.

How to choose the best mask for running

Since runners could exercise outdoors under level 4 restrictions, many in the South African running community have shared their tips, tricks and masks of choice.

While some reckon that a disposable surgical mask makes breathing much easier, others swear by moisture-wicking fabric. Many runners prefer buffs or neck gaiters – not only are these normally made from breathable, moisture-wicking materials, but they cover your neck as well as your face and mouth – which could protect you against the nippy winter air and help you avoid contracting other respiratory conditions.

But all runners are different and have their own preferences. The best way to find what works for you is to try out various masks and methods.

Here are some more tips to keep in mind when choosing which mask you will choose:

  • Your mask or cloth covering should fit over both your mouth and nose.
  • The fit of the mask should be snug enough so that it doesn’t slip down, while not being too restrictive.
  • The mask or cloth covering should consist of two layers.
  • Choose a fabric that feels comfortable on your face, whether it’s cotton or synthetic moisture-wicking material.
  • Cleanliness is an important aspect – don’t reuse your buff or mask before washing it.
  • Trial and error is key – many runners found their preference after experimenting with both a mask and a buff out on runs. 
  • If you have the financial means to invest in new gear, consult outdoor or sports shops for a variety of buffs, or even cloth masks as many retailers have started to sell these. 
  • Although some runners find disposable surgical masks comfortable, these are not sustainable for the environment – they have to be discarded after every run to ensure your safety. 
  • Consider making your own mask or buff from an old moisture-wicking running shirt, as there are many easy-to-follow online tutorials.

Tips for running with a mask

While most of us are exercising in crowded urban settings in South Africa, our Health Department is making masks mandatory while exercising outside. If you have slowly picked up your running again, but are struggling to get used to a mask, these tips may help:

  • Try exhaling through your nose, as this produces fewer respiratory drops than mouth breathing, which will help keep your mask drier and cooler.
  • Don’t try and increase your pace just yet. Don’t put pressure on yourself to improve your performance during this time. Slack off to a pace that will allow you to breathe comfortably and work out at the optimum heart rate while wearing a mask.
  •  Listen to your body and stop when you feel dizzy or fatigued. When you are really struggling to breathe, move away from other people on your route and uncover your mouth and nose for a short while.

Keep general safety in mind

We are currently not allowed to run in organised groups or with people from outside our households. Running alone means that you may be more susceptible to crime. It is therefore important to pay attention to these safety tips:

  • If you run on your own, let a member of your household know exactly how long you plan to run, and which route you’ll be taking.
  • Carry pepper spray and be vigilant.
  • If you run with earphones, keep the volume low to be completely aware of your surroundings.
  • Wear reflective gear and bright colours to be more visible to drivers.
  •  Slow down as soon as you start feeling faint or dizzy while running.

Image credit: 

NEXT ON HEALTH24X

Share Button

Virus cases down to 5,600 a day, says ONS survey

The estimate is based on tests on people living in 9,000 households in England.

Share Button

Coronavirus: Dementia deaths up during pandemic

Deaths due to dementia rose in the first two months of the pandemic, official figures show.

Share Button

Coronavirus: AstraZeneca to begin making potential vaccine

AstraZeneca says it could provide two billion doses of a potential vaccine, helped by backing from Bill Gates.

Share Button

Health24.com | Pulmonary rehab can help people with COPD. So why do so few get it?

Roughly 16 million Americans have chronic obstructive pulmonary disease (COPD), but only a fraction have access to a lifesaving treatment called pulmonary rehabilitation.

COPD is a family of diseases, including emphysema and chronic bronchitis, that make breathing difficult and worsens over time. The main cause is smoking. Other causes include secondhand smoke and exposure to polluted air, chemical fumes or dusts. There is no cure.

But pulmonary rehab can help after a hospital stay, according to Dr David Mannino, director of the Pulmonary Epidemiology Research Laboratory at the University of Kentucky, in Lexington.

Pulmonary rehab teaches patients to exercise, eat well and use medications appropriately in order to regain their strength. Rehab clinics can also foster socialisation, as COPD patients often feel isolated, Mannino said.

Striking differences in outcome

To learn more, a team from the University of Massachusetts studied data from almost 200 000 Medicare patients hospitalised for COPD in 2014. The findings were published on 12 May in the Journal of the American Medical Association.

Of that group, 1.5% (2 721 patients) began pulmonary rehabilitation within 90 days of leaving the hospital. In total, just over 38 300 patients died within one year of discharge from the hospital.

The difference in the outcomes between those who had rehab within 90 days and those who didn’t was striking: Within a year of discharge, 19.6% of the group who did not have early rehab had died, compared with 7.3% of patients who began rehab within 90 days.

“If this were a medication, it would be a blockbuster,” Mannino said. “The tragedy is that it’s only available to such a small percentage.”

Dr Carolyn Rochester, a pulmonologist at Yale School of Medicine in New Haven, Connecticut, examined the reasons why in an editorial that accompanied the findings.

Trying to close the gaps

Rochester noted that doctors are not incentivised to discuss or refer patients to rehab and, even when they do, many don’t follow through because they don’t know the potential benefits or lack access. The programmes are not widely available, and are severely underfunded, she added.

One group that is trying to close the gaps is the Maryland-based Dorney-Koppel Family Charitable Foundation, which provides startup funding for pulmonary rehab clinics in areas where COPD is common.

Its spokeswoman is Grace Anne Dorney Koppel, who emerged as an advocate for COPD patients after she was diagnosed with the disease in 2001. Doctors told her at the time she had only a few years to live, she recalled. But after beginning pulmonary rehabilitation, everything changed.

“I have not only survived, but I have survived well,” she said.

Through their foundation, she and her husband, broadcast journalist Ted Koppel, have established 12 pulmonary rehabilitation clinics across the country and will soon open a 13th. The walls of her office are filled with photographs of graduates from the clinics the couple started.

Increased funding needed

“It is the most gratifying and satisfying thing,” she said. “I see lives made almost whole again, and that is why we do what we do.”

In her editorial, Rochester said access is key.

She said increased health system funding for pulmonary rehab would be a big help.

Rochester also pointed to the need for a randomised clinical trial that would include younger patients and those who have had long stays in acute hospital or nursing facilities. The average age of patients in the UMass study was 76.9 years.

With the world’s attention on Covid-19, Dorney Koppel said her focus is on COPD patients who are highly affected by the disease. That includes the many individuals who may not even know they have COPD, which leaves them vulnerable to contracting the virus.

Image credit: Getty

Share Button

Applying symptom tracking to COVID-19 outpatient care using famotidine

A patient-reported symptom tracking method used for patients with cancer has now been adapted for patients with COVID-19. Investigating the effect of famotidine, a potential treatment for COVID-19, on non-hospitalized patients with COVID-19, clinicians at Northwell Health and cancer researchers at Cold Spring Harbor Laboratory (CSHL) developed the method to use in addition to laboratory tests. This outpatient approach addresses the need to care for the majority of COVID-19 patients who do not require hospitalization. The first clinical case series showed that famotidine may help patients with mild to moderately severe symptoms from COVID-19. Next, the team will test the drug in a randomized clinical trial.

Published in the journal GUT, the Northwell-CSHL case series is unique in its adaptation of quantitative tracking of patient-reported outcome measures. The methodology is suitable for testing drugs in patients well enough to be managed at home and allows the recruitment of diverse subjects via community-based health organizations and individual practitioners.

The lead author of the study, CSHL Assistant Professor Tobias Janowitz, is a Medical Oncologist and a Cancer Researcher, who investigates the whole-body causes and effects of diseases. “The experience of a patient at one point in time is very valuable, but learning about the change in their experience over time is even more important,” says Janowitz. “Change indicates if the patients’ condition is getting better or worse. A graded symptom score enables the physician and the patient to track symptoms using numbers.”

Observing that for COVID-19, most symptomatic people do not require hospitalization, Janowitz and colleagues developed a 4-point scale for six common COVID-19 associated symptoms that patients score every day. Janowitz simplifies how the scale can help track the course of a patient’s disease:

“You may call up your doctor and say, I have headaches and shortness of breath, and am only able to do the basics for self-care, which would be grade 3 symptoms. If you still had the symptoms two days later, but are now able to do light work, these symptoms would now be scored at grade 2. This approach makes it very easy for you and your doctor to document that your symptoms are improving. The value of this approach from a research perspective is that experiences from many patients become comparable and can be pooled for analysis.”

If a drug speeds recovery, then most patients will report more rapid improvement of symptoms.

The innovations in this study are the product of scientists and physicians who never expected to work on a pandemic infection. But the collaborative, multidisciplinary approach is a hallmark of the strategic research affiliation between CSHL and the academic physicians at Northwell Health. Chief, General Internal Medicine, Northwell Health and Professor at the Feinstein Institutes, and a co-author on the study, Joseph Conigliaro says:

“There are a lot of things that we were doing that worked well in how we address this pandemic. I’m a health services addiction researcher. I didn’t think I’d ever be the person who would be studying this pandemic and this virus. And Tobias does cancer research. What we did is we used our existing tools and talents that were not specifically geared towards studying a viral pandemic, but we used it and modified it in ways that were very, very helpful.”

CSHL Professor David Tuveson, Director of the CSHL Cancer Center and another co-author, is interested in the broader implications of the patient-oriented research approach as a way to better connect science and healthcare. CSHL’s commitment to bridging the gap between research and the clinic is evident in an initiative championed by Janowitz to study how disease impacts the entire body. Tuveson says:

“You’re trying to scientifically assess a symptom, is what you’re really doing. Tobias and his colleagues can look at the whole body while they study cancer. And so Tobias is someone who thinks about the big picture of health. He’s basically shifting his approach to solving complex problems to COVID-19 and he started by saying ‘how can we describe one patient relative to the next?'”

Janowitz agrees, “It seems reasonable to me to make that extension to this healthcare crisis and to acknowledge that we can learn a lot from the individual who has the disease as long as we find a way to make it quantifiable.”

Once validated, the patient-reported symptom tracking method will be a key component in a clinical trial that is “double-blind,” meaning that neither patient nor doctor know whether the patient is getting the test drug or a placebo until the trial is completed. Without a double-blind clinical trial and a careful scientific examination of the mechanism of action of a drug and its side effects, it is impossible to rule out that the preliminary findings were due to factors other than the drug. The early findings of this case series were communicated to co-author Dr. Timothy Wang at Columbia University Medical Center. Interestingly, Dr. Wang and colleagues were also able to find an association between famotidine usage and the improved outcomes of patients hospitalized for COVID-19. Based on the findings in the case series, a double-blind clinical trial of famotidine is the next step in the joint plan of the Northwell-CSHL team. Other treatments may also be explored.

Conigliaro explains why he is hopeful that the study will work as designed to find drugs that will be effective against COVID-19:

“We had about a thousand patients that we tracked in our practices, just in my couple of academic practices, that never made it to the hospital. And my Doc’s were calling them every day and asking all those questions: ‘Do you have aches and pains? Do you have fever today? How’s your breathing today?’ We didn’t know what their blood levels were. We didn’t know what their oxygen levels, because we didn’t have access to that. So these surrogate measures are very common and the best way to assess what’s going on in the outpatient. I’m actually pretty confident. I think there’ll be another surge but I think we’ll be much better prepared and I think that hopefully lives will be saved.”

Share Button

Coronavirus: No return to ‘business as usual’ for dentists

Practices in England can reopen from Monday, but many say they will not be ready.

Share Button

‘Tens of thousands’ of heart procedures delayed by pandemic

The backlog for care is putting people’s lives at risk, says the British Heart Foundation.

Share Button